VDAC2 and pancreatic ductal adenocarcinoma: Wang et al. have reported that the knockdown of VDAC2 increased the mitochondrial membrane potential and total ROS levels in pancreatic ductal adenocarcinoma cells, and VDAC2 knockdown potentiated the apoptosis induced by chemotherapy [23].